Artigos de revistas sobre o tema "BCL7"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "BCL7".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Dietrich, Nicholas, Kevin Trotter, James M. Ward e Trevor K. Archer. "BRG1 HSA domain interactions with BCL7 proteins are critical for remodeling and gene expression". Life Science Alliance 6, n.º 5 (17 de fevereiro de 2023): e202201770. http://dx.doi.org/10.26508/lsa.202201770.
Texto completo da fonteJadayel, Dalal M., Lucy R. Osborne, Lionel J. A. Coignet, Valter J. Zani, Lap-Chee Tsui, Stephen W. Scherer e Martin J. S. Dyer. "The BCL7 gene family: deletion of BCL7B in Williams syndrome". Gene 224, n.º 1-2 (dezembro de 1998): 35–44. http://dx.doi.org/10.1016/s0378-1119(98)00514-9.
Texto completo da fonteMcBride, Amanda, Clare M. Adams, Ramkrishna Mitra e Christine M. Eischen. "Bclw Overexpression Predicts Aggressive Disease in B-Cell Lymphomas". Blood 136, Supplement 1 (5 de novembro de 2020): 29. http://dx.doi.org/10.1182/blood-2020-142545.
Texto completo da fonteKahraman, Dudu Solakoglu, Gulden Diniz, Cengiz Ceylan, Faruk Recep Ozalp, Yetkin Koca, Sumeyye Ekmekci, Duygu Ayaz e Sevil Sayhan. "Prognostic impact of BCL2, BCL6 and MYC status in de novo diffuse large B-cell lymphoma: a regional study of 43 patients". International Journal of Research in Medical Sciences 7, n.º 5 (26 de abril de 2019): 1720. http://dx.doi.org/10.18203/2320-6012.ijrms20191665.
Texto completo da fonteSun, Guoxian, e Lya Montella. "Oncogene Amplification as an Incidental Finding in FISH Testing for Gene Rearrangements in Lymphoid Hematopoietic Neoplasms". Blood 118, n.º 21 (18 de novembro de 2011): 2505. http://dx.doi.org/10.1182/blood.v118.21.2505.2505.
Texto completo da fonteGonzález de Villambrosia, Sonia, Mercedes Colorado, Andres Insunza, Ana Batlle, Brenda López-Pereira, Guillermo Martin, Paloma Ibarrondo, Santiago Montes-Moreno e Eulogio Conde. "B Cell Lymphoma Unclassifiable, with Features Intermediate Between Diffuse Large B Cell Lymphoma and Burkitt Lymphoma and Diffuse Large B Cell Lymphoma NOS with Doble/Triple Translocations: Immunophenotypic Analysis". Blood 126, n.º 23 (3 de dezembro de 2015): 5037. http://dx.doi.org/10.1182/blood.v126.23.5037.5037.
Texto completo da fonteLeski, Tomasz A., Clayton C. Caswell, Marcin Pawlowski, David J. Klinke, Janusz M. Bujnicki, Sean J. Hart e Slawomir Lukomski. "Identification and Classification of bcl Genes and Proteins of Bacillus cereus Group Organisms and Their Application in Bacillus anthracis Detection and Fingerprinting". Applied and Environmental Microbiology 75, n.º 22 (18 de setembro de 2009): 7163–72. http://dx.doi.org/10.1128/aem.01069-09.
Texto completo da fonteDupont, Thibault, Zhenghong Dong, ShaoNing Yang, Ari Melnick e Leandro Cerchietti. "Combinatorial Targeting of BCL6 and Anti-Apoptotic Proteins in Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)". Blood 120, n.º 21 (16 de novembro de 2012): 64. http://dx.doi.org/10.1182/blood.v120.21.64.64.
Texto completo da fontePophali, Priyanka, Lisa M. Marinelli, Rhett P. Ketterling, Reid Gregory Meyer, Ellen D. McPhail, Paul J. Kurtin, Thomas M. Habermann e Rebecca L. King. "High Level MYC Amplification in Aggressive B-Cell Lymphomas: Is It a Marker of Aggressive Disease?" Blood 132, Supplement 1 (29 de novembro de 2018): 1693. http://dx.doi.org/10.1182/blood-2018-99-115484.
Texto completo da fontePedersen, Mette Ølgod, Anne Ortved Gang, Tim Svenstrup Poulsen, Helle Knudsen, Anne F. Lauritzen, MajLis M. Talman, Signe Ledou Nielsen e Peter H. Norgaard. "Concurrent BCL2 and MYC Translocations In a Prospective Cohort of Diffuse Large B-Cell Lymphomas". Blood 116, n.º 21 (19 de novembro de 2010): 319. http://dx.doi.org/10.1182/blood.v116.21.319.319.
Texto completo da fonteShivam, Saloni, Mansour El-Matbouli e Gokhlesh Kumar. "Kinetics of Parasite-Specific Antibody and B-Cell-Associated Gene Expression in Brown Trout, Salmo trutta during Proliferative Kidney Disease". Biology 10, n.º 12 (28 de novembro de 2021): 1244. http://dx.doi.org/10.3390/biology10121244.
Texto completo da fontePalathingal Bava, E., W. liu, Y. Shen, X. Fang, J. Carey, J. C. Gomez-Gelvez, K. Inamdar e S. Ghosh. "Composite Lymphoma Comprising of BCL2 Rearrangement Negative, CD23 Positive Follicle Center Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Case Report". American Journal of Clinical Pathology 162, Supplement_1 (outubro de 2024): S75—S76. http://dx.doi.org/10.1093/ajcp/aqae129.167.
Texto completo da fontePiovan, Erich, Masumichi Saito, Katia Basso, Urban Novak, Qiong Shen, Laura Pasqualucci e Riccardo Dalla-Favera. "Direct Transcriptional Repression of BCL2 by BCL6 in Germinal Centre B Cells and Its Disruption in B Cell Lymphomas with BCL2 Locus Alterations". Blood 112, n.º 11 (16 de novembro de 2008): 296. http://dx.doi.org/10.1182/blood.v112.11.296.296.
Texto completo da fonteNavarro, Jose-Tomas, Maria Joao Baptista, Alejandra Martinez-Trillos, Gustavo Tapia, Jose Angel Hernandez-Rivas, Olga Garcia, Anna Muñoz-Marmol et al. "Lymphomas With MYC-Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases". Blood 122, n.º 21 (15 de novembro de 2013): 5083. http://dx.doi.org/10.1182/blood.v122.21.5083.5083.
Texto completo da fonteBotto, Barbara, Domenico Novero, Annalisa Chiappella, Mattia Novo, Alessia Castellino, Chiara Ciochetto, Giovanni Cametti et al. "The Prognostic Value of MYC, BCL2 and BCL6 Overexpression Evaluated By Immunohistochemistry (IHC) in De-Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Rituximab-CHOP". Blood 124, n.º 21 (6 de dezembro de 2014): 2964. http://dx.doi.org/10.1182/blood.v124.21.2964.2964.
Texto completo da fonteYang, Ge, Pin Wan, Qi Xiang, Shanyu Huang, Siyu Huang, Jun Wang, Kailang Wu e Jianguo Wu. "E3 Ubiquitin Ligase ASB17 Promotes Apoptosis by Ubiquitylating and Degrading BCLW and MCL1". Biology 10, n.º 3 (18 de março de 2021): 234. http://dx.doi.org/10.3390/biology10030234.
Texto completo da fonteHildebrand, Johannes Adrian, Sarah Haebe, Verena Passerini, Michael Heide, William Keay, Louisa Adolph, Lukas Ulrich et al. "Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies". Blood 142, Supplement 1 (28 de novembro de 2023): 4358. http://dx.doi.org/10.1182/blood-2023-174384.
Texto completo da fontePatel, Priyank P., Pallawi Torka, Vishala T. Neppalli, George Deeb, Sheila N. J. Sait, AnneMarie W. Block, Seema A. Bhat, Myron S. Czuczman e Francisco J. Hernandez-Ilizaliturri. "Intense Cytarabine-Based Chemo-Immunotherapy, Central Nervous System (CNS) Prophylaxis and Early High-Dose Chemotherapy and Autologous Stem Cell Support (HDC-ASCS) in First Remission Are Associated with an Improved Clinical Outcome in Double-Hit (DHL)/Triple-Hit (THL) Diffuse Large B-Cell Lymphoma (DLBCL)". Blood 124, n.º 21 (6 de dezembro de 2014): 3031. http://dx.doi.org/10.1182/blood.v124.21.3031.3031.
Texto completo da fonteSwerdlow, Steven H. "Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC". Hematology 2014, n.º 1 (5 de dezembro de 2014): 90–99. http://dx.doi.org/10.1182/asheducation-2014.1.90.
Texto completo da fonteCarey, Christopher Daniel, Daniel Gusenleitner, Zhang Xuan, Aliyah R. Sohani, Olga Weinberg, Hongbo Yu, Ben Chen et al. "Resolving the Biological Heterogeneity of B-Cell Lymphoma, Unclassifiable, with Features Intermediate Between DLBCL and BL (BCL-U) Using Quantitative Profiles of Oncogenic Signaling Networks". Blood 126, n.º 23 (3 de dezembro de 2015): 3903. http://dx.doi.org/10.1182/blood.v126.23.3903.3903.
Texto completo da fonteWalia, Jasmit, Timothy Daly, Ali Tahir, Melissa Wilson e Kunal Bhagatwala. "A case of triple hit lymphoma and rapid deterioration". Journal of Case Reports and Images in Oncology 9, n.º 1 (21 de março de 2023): 8–11. http://dx.doi.org/10.5348/100118z10jw2023cr.
Texto completo da fonteTrajkova, Sanja, Svetlana Krstevska-Balkanov, Gordana Petrusevska, Lidija Cevreska, Aleksandra Pivkova-Veljanovska, Marija Popova-Labacevska, Nevenka Ridova, Simona Stojanovska e Irina Panovska-Stavridis. "Prognostic impact of immunophenotyping of diffuse large B-cell lymphoma - a single-centre experience". Macedonian Pharmaceutical Bulletin 67, n.º 1 (2021): 43–54. http://dx.doi.org/10.33320/10.33320/maced.pharm.bull.2021.67.01.005.
Texto completo da fonteArun Kumar, Sumukh, Rahul Mishra, Sarat Chandra Malempati e Poorva Bindal. "Primary cardiac large B cell lymphoma". BMJ Case Reports 16, n.º 12 (dezembro de 2023): e256167. http://dx.doi.org/10.1136/bcr-2023-256167.
Texto completo da fonteKawakami, Keiki, Setsuko Miyanishi, Takashi Sonoki, Shigeo Nakamura, Kenichi Nomura, Kenichi Nomura, Tetsuya Murata, Shigenori Kadowaki, Shigenori Kadowaki e Ikuo Miura. "Case of B-Cell Lymphoma with Rearrangement of the BCL1, BCL2, BCL6, and c-MYC Genes". International Journal of Hematology 79, n.º 5 (1 de junho de 2004): 474–79. http://dx.doi.org/10.1532/ijh97.03105.
Texto completo da fonteAmallraja, Anu, Gunes Gundem, Dylan Domenico, Juan E. Arango Ossa, Umut Aypar, Jeeyeon Baik, Michael Kluk et al. "Genomic Characterization and Classification of BCL6 Rearranged Follicular Lymphomas". Blood 144, Supplement 1 (5 de novembro de 2024): 1589. https://doi.org/10.1182/blood-2024-203770.
Texto completo da fonteHaralambieva, Eugenia, Evert-jan Boerma, Gustaaf van Imhoff, Stefano Rosati, Ed Schuuring, Hans-Konrad Mueller-Hermelink, Philip M. Kluin e German Ott. "The Grey Zone between Burkitt and Diffuse Large B Cell Lymphomas: Impact of Chromosomal Breakponts at Myc and Other Loci." Blood 104, n.º 11 (16 de novembro de 2004): 2275. http://dx.doi.org/10.1182/blood.v104.11.2275.2275.
Texto completo da fonteCi, Weimin, Jose M. Polo, Leandro Cerchietti, Rita Shaknovich, Ling Wang, Shao Ning Yang, Kenny Ye et al. "The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL". Blood 113, n.º 22 (28 de maio de 2009): 5536–48. http://dx.doi.org/10.1182/blood-2008-12-193037.
Texto completo da fonteBiehl, Holger, Jeremy C. Creasey, David M. Smith, Richard P. Tuckett, Karl R. Yoxall, Helmut Baumgartel, Hans W. Jochims e Ulriche Rockland. "Vacuum UV fluorescence excitation spectroscopy of BCl3. Electronic spectroscopy of BCl2, BCl2 + and BCl3 +". Journal of the Chemical Society, Faraday Transactions 91, n.º 18 (1995): 3073. http://dx.doi.org/10.1039/ft9959103073.
Texto completo da fonteDierlamm, J., S. Pittaluga, I. Wlodarska, M. Stul, J. Thomas, M. Boogaerts, L. Michaux, A. Driessen, C. Mecucci e JJ Cassiman. "Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features [see comments]". Blood 87, n.º 1 (1 de janeiro de 1996): 299–307. http://dx.doi.org/10.1182/blood.v87.1.299.299.
Texto completo da fonteDierlamm, J., S. Pittaluga, I. Wlodarska, M. Stul, J. Thomas, M. Boogaerts, L. Michaux, A. Driessen, C. Mecucci e JJ Cassiman. "Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features [see comments]". Blood 87, n.º 1 (1 de janeiro de 1996): 299–307. http://dx.doi.org/10.1182/blood.v87.1.299.bloodjournal871299.
Texto completo da fonteTsai, Cheng-Chih, Yung-Cheng Su, Oluwaseun Adebayo Bamodu, Bo-Jung Chen, Wen-Chiuan Tsai, Wei-Hong Cheng, Chii-Hong Lee et al. "High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan". Cancers 13, n.º 7 (31 de março de 2021): 1620. http://dx.doi.org/10.3390/cancers13071620.
Texto completo da fonteHorn, Heike, Marita Ziepert, Thomas F. E. Barth, Heinz-Wolfram Bernd, Martin Wartenberg, Alfred C. Feller, Wolfram Klapper et al. "The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL". Blood 122, n.º 21 (15 de novembro de 2013): 4262. http://dx.doi.org/10.1182/blood.v122.21.4262.4262.
Texto completo da fonteMa, Zhiping, Jing Niu, Yanzhen Cao, Xuelian Pang, Wenli Cui, Wei Zhang e Xinxia Li. "Clinical significance of ‘double-hit’ and ‘double-expression’ lymphomas". Journal of Clinical Pathology 73, n.º 3 (15 de outubro de 2019): 126–38. http://dx.doi.org/10.1136/jclinpath-2019-206199.
Texto completo da fonteVallespi, Teresa, Margarita Ortega, Anny Jaramillo, Laura Lopez-Andreoni, Noemi Martínez-Morgado, Carmen Sánchez e Francesc Bosch. "T(8;22)(q24;q11) In a Context of Complex Karyotype In Two Patients with B-Cell Lymphoma with Features Intermediate Between Burkitt Lymphoma and Diffuse Large B Cell Lymphoma B (LB/LDCGB)". Blood 116, n.º 21 (19 de novembro de 2010): 5093. http://dx.doi.org/10.1182/blood.v116.21.5093.5093.
Texto completo da fonteAbramson, Jeremy S., Jeffrey A. Barnes, Yang Feng, Tak Takvorian, Donna S. Neuberg, Ephraim P. Hochberg e Aliyah R. Sohani. "Double Hit Lymphomas: Evaluation of Prognostic Factors and Impact of Therapy". Blood 120, n.º 21 (16 de novembro de 2012): 1619. http://dx.doi.org/10.1182/blood.v120.21.1619.1619.
Texto completo da fonteWorrillow, Lisa J., Rob Newton e Andrew S. Jack. "The Pattern of BCL6 Intron 1 Mutations in Healthy Individuals with BCL2;IgH Is Similar to That Seen in Lymphomas". Blood 112, n.º 11 (16 de novembro de 2008): 3800. http://dx.doi.org/10.1182/blood.v112.11.3800.3800.
Texto completo da fonteKramer, M. H. H., J. Hermans, E. Wijburg, K. Philippo, E. Geelen, J. H. J. M. van Krieken, D. de Jong, E. Maartense, E. Schuuring e P. M. Kluin. "Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma". Blood 92, n.º 9 (1 de novembro de 1998): 3152–62. http://dx.doi.org/10.1182/blood.v92.9.3152.
Texto completo da fonteKramer, M. H. H., J. Hermans, E. Wijburg, K. Philippo, E. Geelen, J. H. J. M. van Krieken, D. de Jong, E. Maartense, E. Schuuring e P. M. Kluin. "Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma". Blood 92, n.º 9 (1 de novembro de 1998): 3152–62. http://dx.doi.org/10.1182/blood.v92.9.3152.421a07_3152_3162.
Texto completo da fonteRossi, Davide, Valeria Spina, Clara Deambrogi, Marco Lucioni, Luca Arcaini, Gabrielle B. Rocque, Jeffrey T. Malik et al. "TP53 Mutations, the Most Frequent Genetic Lesion in Richter Syndrome, Represent An Independent Predictor of Survival Post Transformation." Blood 114, n.º 22 (20 de novembro de 2009): 670. http://dx.doi.org/10.1182/blood.v114.22.670.670.
Texto completo da fonteSakruti, Susmita, Nabila Bennani, Swapna Thota, Rohan Garje, Adewale Fawole, Paul Elson, Abdo Haddad, Timothy Spiro e Hamed Daw. "Diffuse Large B Cell Lymphoma: Role Of MYC, BCL2, BCL6 Protein Expressions and Translocations". Blood 122, n.º 21 (15 de novembro de 2013): 5055. http://dx.doi.org/10.1182/blood.v122.21.5055.5055.
Texto completo da fonteParkhi, Mayur, Debajyoti Chatterjee, Bishan Dass Radotra, Amanjit Bal, Budhi Singh Yadav e Manjul Tripathi. "Double-hit and double-expressor primary central nervous system lymphoma: Experience from North India of an infrequent but aggressive variant". Surgical Neurology International 14 (12 de maio de 2023): 172. http://dx.doi.org/10.25259/sni_307_2023.
Texto completo da fonteMeriranta, Leo, Annika Pasanen, Marja-Liisa Karjalainen-Lindsberg, Sandeep Dave e Sirpa Leppa. "Clinical and Biological Features behind Hallmark Aberrations in Diffuse Large B-Cell Lymphoma". Blood 132, Supplement 1 (29 de novembro de 2018): 2976. http://dx.doi.org/10.1182/blood-2018-99-117958.
Texto completo da fontePajor, László, József Kun, Róbert Herczeg, Bence Gálik, Zsombor Ritter, Anett Baliko, Géza Hegedűs et al. "A diffúz nagy B-sejtes limfóma fenotipikus, citogenetikai és expressziós profil heterogenitása – Magyarországi multicentrikus tanulmány". Hematológia–Transzfuziológia 55, n.º 4 (4 de abril de 2023): 154–63. http://dx.doi.org/10.1556/2068.2023.00157.
Texto completo da fontePatel, Priyank P., Alison Zeccola, Vishala T. Neppalli, Juan J. Gu, Cory Mavis, Sheila Sait e Francisco J. Hernandez-Ilizaliturri. "Pre-Clinical Investigation of Targeted Therapies for Double Hit Diffuse Large B-Cell Lymphoma (DH-DLBCL)". Blood 126, n.º 23 (3 de dezembro de 2015): 5122. http://dx.doi.org/10.1182/blood.v126.23.5122.5122.
Texto completo da fonteSaksena, Annapurna, Parth Desai, Zhuang Zuo, Jie Xu, Pei Lin, Adam C. Seegmiller, C. Cameron Yin et al. "MYC/BCL2 Double Hit Lymphoma: What Really Matters". Blood 126, n.º 23 (3 de dezembro de 2015): 3909. http://dx.doi.org/10.1182/blood.v126.23.3909.3909.
Texto completo da fonteKhurana, Arushi, Raphael Mwangi, James R. Cerhan, Jonathon B. Cohen, Jennifer R. Chapman-Fredricks, Jonathan W. Friedberg, Christopher R. Flowers et al. "Comparing Clinical Characteristics and Outcomes of MYC and BCL6 Double Hit Lymphoma (DHL- BCL6) with Other Aggressive B-Cell Lymphomas: Understanding the Impact of New Who and International Consensus Classifications". Blood 142, Supplement 1 (28 de novembro de 2023): 67. http://dx.doi.org/10.1182/blood-2023-190316.
Texto completo da fonteMisyurina, A. E., S. K. Kravchenko, A. M. Kovrigina, A. U. Magomedova, L. V. Plastinina, T. N. Obukhova, A. V. Misyurin et al. "The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data". Terapevticheskii arkhiv 91, n.º 7 (15 de julho de 2019): 52–62. http://dx.doi.org/10.26442/00403660.2019.07.000070.
Texto completo da fonteLandsburg, Daniel J., Marissa K. Falkiewicz, Jennifer J. D. Morrissette, April M. Schrank-Hacker, Sunita Dwivedy Nasta, Jakub Svoboda, Stephen J. Schuster et al. "Patients with "Single-Hit" but Not MYC -Amplified Non-Burkitt High-Grade B Cell Non-Hodgkin Lymphomas Experience Poor Survival Outcomes and May Benefit from Intensive Induction Therapy". Blood 126, n.º 23 (3 de dezembro de 2015): 2696. http://dx.doi.org/10.1182/blood.v126.23.2696.2696.
Texto completo da fonteAdam, Ammar, Kate Byth, Paul Secrist, Alwin Schuller, Corinne Reimer, Deborah Lawson, Terry MacIntyre e Francoise Powell. "A Dual Bcl-2/xL Inhibitor Induces Tumor Cell Apoptosis in a Hematopoietic Xenograft Model". Blood 124, n.º 21 (6 de dezembro de 2014): 5304. http://dx.doi.org/10.1182/blood.v124.21.5304.5304.
Texto completo da fonteShen, Yige, Shu Cheng, Pengpeng Xu, Li Wang e Weili Zhao. "Clinical and Molecular Features of Patients with Double/Triple Hit Large B-Cell Lymphoma". Blood 142, Supplement 1 (28 de novembro de 2023): 4488. http://dx.doi.org/10.1182/blood-2023-188042.
Texto completo da fonte